Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6003)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2013 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ishikawa T. Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma. World J Gastroenterol 2013; 19(37): 6127-6130 [PMID: 24115808 DOI: 10.3748/wjg.v19.i37.6127] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v19/i37/6127.htm |
| Number | Citing Articles |
| 1 |
Jiansong Wu, Zhiwei Yin, Liuxia Cao, Xiaodan Xu, Tao Yan, Changting Liu, Diangeng Li. Adjuvant pegylated interferon therapy improves the survival outcomes in patients with hepatitis-related hepatocellular carcinoma after curative treatment. Medicine 2018; 97(28): e11295 doi: 10.1097/MD.0000000000011295
|
| 2 |
Rony Kampalath, Karen Tran-Harding, Richard K.G. Do, Mishal Mendiratta-Lala, Vahid Yaghmai. Evaluation of Hepatocellular Carcinoma Treatment Response After Locoregional Therapy. Magnetic Resonance Imaging Clinics of North America 2021; 29(3): 389 doi: 10.1016/j.mric.2021.05.013
|
| 3 |
Evangelos Stournaras, Georgios Neokosmidis, Dimitrios Stogiannou, Andreas Protopapas, Konstantinos Tziomalos. Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis. European Journal of Gastroenterology & Hepatology 2018; 30(11): 1277 doi: 10.1097/MEG.0000000000001254
|
| 4 |
|
| 5 |
SHUJI SUMIE, TAKUMI KAWAGUCHI, ATSUSHI KAWAGUCHI, RYOKO KUROMATSU, MASAHITO NAKANO, MANABU SATANI, SHINGO YAMADA, SHUSUKE OKAMURA, YUKO YONEZAWA, TATSUYUKI KAKUMA, TAKUJI TORIMURA, MICHIO SATA. Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study. Molecular and Clinical Oncology 2015; 3(1): 115 doi: 10.3892/mco.2014.435
|
| 6 |
Qiujin Shen, Xin-Rong Yang, Yexiong Tan, Haiyan You, Yang Xu, Wei Chu, Tianxiang Ge, Jian Zhou, Shuang-Jian Qiu, Ying-Hong Shi, Zhigang Zhang, Jianren Gu, Hongyang Wang, Jia Fan, Wenxin Qin. High level of serum protein DKK1 predicts poor prognosis for patients with hepatocellular carcinoma after hepatectomy. Hepatic Oncology 2015; 2(3): 231 doi: 10.2217/hep.15.12
|
| 7 |
Hend Ibrahim Shousha, Rabab Fouad, Tamer Mahmoud Elbaz, Dina Sabry, Mohamed Mahmoud Nabeel, Ahmed Hosni Abdelmaksoud, Aisha Mahmoud Elsharkawy, Zeinab Abdellatif Soliman, Ghada Habib, Ashraf Omar Abdelaziz. Predictors of recurrence and survival of hepatocellular carcinoma: A prospective study including transient elastography and cancer stem cell markers. Arab Journal of Gastroenterology 2020; 21(2): 95 doi: 10.1016/j.ajg.2020.04.002
|
| 8 |
Nadia F. El Ameen, Hosny S. Abdel Ghany, Mostafa M. Elian, Tamer El Zaeem. MDCT assessment of HCC patient after radiofrequency ablation among Egyptian population: Preliminary experience. The Egyptian Journal of Radiology and Nuclear Medicine 2014; 45(2): 409 doi: 10.1016/j.ejrnm.2014.02.003
|
| 9 |
Nicola Coppola, Mariantonietta Pisaturo, Caterina Sagnelli, Lorenzo Onorato, Evangelista Sagnelli. Role of genetic polymorphisms in hepatitis C virus chronic infection. World Journal of Clinical Cases 2015; 3(9): 807-822 doi: 10.12998/wjcc.v3.i9.807
|
| 10 |
Raphael Iglesias de Oliveira Vidal, Edison Iglesias de Oliveira Vidal, Basilio de Bragança Pereira, Cachimo Combo Assane, Alexandre Ribeiro, Emilia Matos do Nascimento, Fernando Gomes Romeiro, Joaquim Ribeiro Filho, Ran Wang. Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1487593
|
| 11 |
Hinako Kimura, Naoya Matsunaga, Keisuke Kakimoto, Miyako Watanabe, Akito Tsuruta, Naoki Kusunose, Shoya Shiromizu, Satoru Koyanagi, Shigehiro Ohdo. Epithelial cell adhesion molecule expression in hepatic stem/progenitor cells is controlled by the molecular clock system. Biochemical and Biophysical Research Communications 2018; 503(2): 1063 doi: 10.1016/j.bbrc.2018.06.117
|
| 12 |
Nicola Coppola, Mariantonietta Pisaturo, Rosa Zampino, Margherita Macera, Caterina Sagnelli, Evangelista Sagnelli. Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals. World Journal of Gastroenterology 2015; 21(38): 10749-10759 doi: 10.3748/wjg.v21.i38.10749
|
| 13 |
Shigeki Nakagawa, Yo-ichi Yamashita, Naoki Umezaki, Takanobu Yamao, Takayoshi Kaida, Yukiharu Hiyoshi, Kosuke Mima, Hirohisa Okabe, Hiromitsu Hayashi, Katsunori Imai, Akira Chikamoto, Hideo Baba. Four gene intrahepatic metastasis–risk signature predicts hepatocellular carcinoma malignant potential and early recurrence from intrahepatic metastasis. Surgery 2021; 169(4): 903 doi: 10.1016/j.surg.2020.09.032
|
| 14 |
Logain Nabil Salem, Dina Moghazy Mohammed, Dina Hazem Ziada, M.H. Elshafey. Dual input computed tomography perfusion in evaluating the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 2018; 49(3): 597 doi: 10.1016/j.ejrnm.2018.01.017
|
| 15 |
Biao Yang, Rui-yu Zan, Shi-yu Wang, Xiang-lian Li, Mao-ling Wei, Wen-hao Guo, Xin You, Jing Li, Zheng-yin Liao. Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials. World Journal of Surgical Oncology 2015; 13(1) doi: 10.1186/s12957-015-0516-7
|
| 16 |
Meile Mo, Xiaoyun Ma, Yihuan Luo, Chao Tan, Bihu Liu, Peng Tang, Qian Liao, Shun Liu, Hongping Yu, Dongping Huang, Xiaoyun Zeng, Xiaoqiang Qiu. Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10186-2
|
| 17 |
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival. World Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
|